Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11769783 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19 | |
| Cyclohexane SCHEMBL9334136 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19 | |
| SCHEMBL110090 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19 | |
| SCHEMBL50228 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19 | |
| SCHEMBL4955809 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19 | |
| SCHEMBL749447 | 1.00 | — | — | |
| SCHEMBL5575197 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19 | |
| SCHEMBL27175 | 1.00 | — | — | |
| SCHEMBL21624980 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19 | |
| SCHEMBL31723393 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119350607-A | Preparation method of high molecular weight poly (alkyl oxalate) homopolymer and copolymer | 青岛科技大学 | 2025-01-24 | — | — | CN | claimed |
| US-3933939-A | UNSATURATED, COATING | KANSAI PAINT COMPANY, LTD. (JA) | 1976-01-20 | — | — | US | claimed |
| EP-4678677-A1 | BISPHENOL DIGLYCIDYL ETHER COMPOSITION, CURABLE COMPOSITION, CURED PRODUCT, AND ELECTRICAL/ELECTRONIC COMPONENT | Mitsubishi Chemical Corporation (JP) | 2026-01-14 | — | — | EP | disclosed |
| US-20260002022-A1 | BISPHENOL DIGLYCIDYL ETHER COMPOSITION, CURABLE COMPOSITION, CURED PRODUCT, AND ELECTRICAL/ELECTRONIC COMPONENT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2026-01-01 | — | — | US | disclosed |
| EP-4650350-A1 | POLYCRYSTALLINE FORM OF BIPHENOL DIGLYCIDYL ETHER, AND RESIN COMPOSITION CONTAINING SAID POLYCRYSTALLINE FORM AND CURED PRODUCT THEREOF | Mitsubishi Chemical Corporation (JP) | 2025-11-19 | — | — | EP | disclosed |
| US-20250340524-A1 | POLYCRYSTALLINE FORM OF BIPHENOL DIGLYCIDYL ETHER, AND RESIN COMPOSITION CONTAINING SAID POLYCRYSTALLINE FORM AND CURED PRODUCT THEREOF | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-11-06 | — | — | US | disclosed |
| EP-4617315-A1 | THERMOPLASTIC POLYMER COMPOSITIONS | Kraton Polymers Nederland B.V. (NL) | 2025-09-17 | — | — | EP | disclosed |
| US-20250206947-A1 | THERMOPLASTIC POLYMER COMPOSITIONS | Kraton Corporation (US) | 2025-06-26 | — | — | US | disclosed |
| WO-2025127036-A1 | EPOXY RESIN, CURABLE COMPOSITION, CURED PRODUCT, AND ELECTRICAL/ELECTRONIC COMPONENT | 三菱ケミカル株式会社 | 2025-06-19 | — | — | WO | disclosed |
| CN-119350607-A | Preparation method of high molecular weight poly (alkyl oxalate) homopolymer and copolymer | 青岛科技大学 | 2025-01-24 | — | — | CN | disclosed |
| WO-2024190555-A1 | BISPHENOL DIGLYCIDYL ETHER COMPOSITION, CURABLE COMPOSITION, CURED PRODUCT, AND ELECTRICAL/ELECTRONIC COMPONENT | 三菱ケミカル株式会社 | 2024-09-19 | — | — | WO | disclosed |
| WO-2008157092-A1 | BIO-FILM RESISTANT SURFACES | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2008-12-24 | — | — | WO | disclosed |
| US-20070037716-A1 | Lubricants for power transmission | IDEMITSU KOSAN CO., LTD. (JP) | 2007-02-15 | — | — | US | disclosed |
| EP-1717297-A1 | Lubricants for power transmission system | Idemitsu Kosan Co., Ltd. (JP) | 2006-11-02 | — | — | EP | disclosed |
| EP-1430012-A2 | METHOD FOR MAKING A SUBSTANTIALLY PURE MIXTURE OF CYCLODODECANEDIOL ISOMERS AND USES THEREOF | INVISTA Technologies S.à.r.l. (US) | 2004-06-23 | — | — | EP | disclosed |
| US-20030069455-A1 | Method for making a substantially pure mixture of cyclododecanediol isomers and uses thereof | INVISTA NORTH AMERICA S.A.R.L. (F/K/A ARTEVA NORTH AMERICA S.A.R.L.) | 2003-04-10 | — | — | US | disclosed |
| WO-2003027052-A2 | METHOD FOR MAKING A SUBSTANTIALLY PURE MIXTURE OF CYCLODODECANEDIOL ISOMERS AND USES THEREOF | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-04-03 | — | — | WO | disclosed |
| EP-0004869-B1 | PROCESS FOR THE MANUFACTURE OF THIXOTROPIC UNSATURATED POLYESTER RESIN SOLUTIONS | Vianova Kunstharz Aktiengesellschaft (AT) | 1982-07-28 | — | — | EP | disclosed |
| US-4297287-A | DEHYDRATION BY REACTING WITH AN ALKALI OR ALKALINE CARBOXYLIC SALT IN THE PRESENCE OF A CARBOXYLIC ACID AND SOLVENT | RHONE-POULENC INDUSTRIES (FR) | 1981-10-27 | — | — | US | disclosed |
| US-3933939-A | UNSATURATED, COATING | KANSAI PAINT COMPANY, LTD. (JA) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250340524-A1 | POLYCRYSTALLINE FORM OF BIPHENOL DIGLYCIDYL ETHER, AND RESIN COMPOSITION CONTAINING SAID POLYCRYSTALLINE FORM AND CURED PRODUCT THEREOF | RPP30, RER1, C9 | ALDH1A1 1716/4885TSHR 3946/4885CYP2C19 1750/4885 |
| US-20260002022-A1 | BISPHENOL DIGLYCIDYL ETHER COMPOSITION, CURABLE COMPOSITION, CURED PRODUCT, AND ELECTRICAL/ELECTRONIC COMPONENT | EBP, MECP2, ESR2 | ALDH1A1 3109/4885TSHR 1570/4885CYP2C19 2934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.